CareStart™ Dengue Combo

Access Bio Inc.

CareStart™ Dengue Combo Contact Solution Provider

Solution Overview & Benefits

Dengue virus is transmitted by mosquitoes, and more than one-third of the world’s population is at risk for infection. Because there are no vaccines available to prevent infection with dengue virus, early recognition and prompt supportive treatment can substantially lower the risk of medical complications and death. CareStart™ Dengue Combo (NS1 Ag+IgM/IgG) is a rapid diagnostic test that can simultaneously detect dengue virus in all clinical stages using both dengue NS1 antigen and anti-dengue antibodies (IgM/IgG) with one device. -Diagnosis of dengue infection from acute to convalescent stage -Detection of all four dengue serotypes from serum, plasma, or whole blood -True point-of-care test with no specimen preparation

History & Development

Specifications Test Type: Qualitative rapid diagnostic test Assay Method: Dengue NS1 Ag+IgM/IgG Storage Temperature: 1- 30℃ Specimen: Serum/Plasma/Whole Blood Specimen Volume: NS1 Ag : 60/60/80㎕ IgM/IgG : 10/10/20㎕ Result Time: 15 – 20 minutes


Publicly available: Yes
Countries where available: Not for sale in the USA
Price range: Contact supplier for quote
Offered or can be licensed for local manufacture: No


Dimensions: 25 or 50 tests per box

Additional Information


If you are aware of any updates to the CareStart™ Dengue Combo project please complete the form or send an email to [email protected]

Need help finding solutions that respond to your unique development challenges? Apply through our Project Accelerator service or Contact us directly for needs-based project consulting.